Skip to main content
Ch. 12 The Central Nervous System
Marieb - Human Anatomy & Physiology 11th Edition
Marieb, Hoehn11th EditionHuman Anatomy & PhysiologyISBN: 9780136874034당신이 사용하는 게 아니라요?교과서 변경
12장, 문제 22

Mrs. Jones has had a progressive decline in her mental capabilities in the last five or six years. At first her family attributed her occasional memory lapses, confusion, and agitation to grief over her husband's death six years earlier. When examined, Mrs. Jones was aware of her cognitive problems and was shown to have an IQ score approximately 30 points less than would be predicted by her work history. A CT scan showed diffuse cerebral atrophy. The physician prescribed an acetylcholinesterase inhibitor and Mrs. Jones showed slight improvement. What is Mrs. Jones's problem? Why did the acetylcholinesterase inhibitor help?

검증된 단계별 안내
1
Step 1: Identify the key symptoms and clinical findings. Mrs. Jones has progressive cognitive decline over several years, memory lapses, confusion, agitation, and a significant drop in IQ score compared to her previous baseline. A CT scan shows diffuse cerebral atrophy, indicating widespread brain tissue loss.
Step 2: Recognize the likely diagnosis. Progressive cognitive decline with memory impairment, cerebral atrophy on imaging, and gradual worsening over years is characteristic of Alzheimer's disease, a neurodegenerative disorder affecting memory and cognition.
Step 3: Understand the role of acetylcholinesterase inhibitors. These drugs inhibit the enzyme acetylcholinesterase, which breaks down acetylcholine, a neurotransmitter important for learning and memory. By inhibiting this enzyme, acetylcholine levels increase in the brain.
Step 4: Explain why the acetylcholinesterase inhibitor helps. In Alzheimer's disease, there is a loss of cholinergic neurons leading to decreased acetylcholine. Increasing acetylcholine availability can temporarily improve cognitive function and slow symptom progression.
Step 5: Summarize the problem and treatment rationale. Mrs. Jones likely has Alzheimer's disease causing her cognitive decline and brain atrophy. The acetylcholinesterase inhibitor helps by enhancing cholinergic neurotransmission, which partially compensates for the loss of acetylcholine-producing neurons.

비슷한 문제에 대한 검증된 영상 답변:

이 영상 해법은 위 문제에 도움이 된다고 튜터들이 추천한 것입니다.
영상 길이:
2m

주요 개념

질문에 올바르게 답하기 위해 반드시 이해해야 하는 핵심 개념들은 다음과 같습니다.

Alzheimer's Disease and Dementia

Alzheimer's disease is a progressive neurodegenerative disorder characterized by memory loss, cognitive decline, and behavioral changes. It is the most common cause of dementia in older adults, often presenting with symptoms like confusion and agitation. Diffuse cerebral atrophy seen on imaging supports this diagnosis by indicating brain tissue loss.
추천 영상:
가이드 코스
3:19
Immune Tolerance

Role of Acetylcholine in Cognition

Acetylcholine is a neurotransmitter crucial for learning and memory processes in the brain. In Alzheimer's disease, cholinergic neurons degenerate, leading to decreased acetylcholine levels. Enhancing acetylcholine availability can improve cognitive function temporarily by supporting neural communication.
추천 영상:
5:56
A. Events at the Neuromuscular Junction

Mechanism of Acetylcholinesterase Inhibitors

Acetylcholinesterase inhibitors block the enzyme that breaks down acetylcholine, increasing its concentration in synapses. This helps compensate for the loss of cholinergic neurons in Alzheimer's disease, leading to modest improvements in memory and cognition, as seen in Mrs. Jones's slight improvement after treatment.
추천 영상:
3:02
Internal Regulation - The Myogenic Mechanism